The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
The TB section of the toolkit presents selected (a) programmatic output and (b) outcome and impact indicators for TB. In addition to recommended monitoring programs and measuring the outcomes and impact of TB programs, indicators for the strengthening of health systems, strengthening of community sy...stems and some indicators that measure quality of services are also included.
more
The Open Infectious Diseases Journal, 2010, 4, 33-37
Key Populations Brief
Accessed November 2017
Discussion paper initially prepared in April 2015 to facilitate feedback, and finalized after the
June 2015 meeting of WHO’s Strategic and Technical Advisory Group for TB (STAG-TB).
Epidemiologisches Bulletin; 1. Dezember 2014 / Nr. 48
Mapping Report - Catalonia (Spain).
Blueprint for EECA countries, first edition
Informe sobre poplaciones clave.
Key populations brief.
МИГРАНТЫ
ОСНОВНЫЕ ЗАТРОНУТЫЕ ГРУППЫ НАСЕЛЕНИЯ. КРАТКОЕ РУКОВОДСТВО.
Rapport sur les populations clés.
Asylum and Migration Working Paper 1